MedTrace Logo

NORDIC ICD (Cardioverter Defibrillator Implantation) Trial

NCT01282918 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1077

Last updated 2015-06-23

No results posted yet for this study

Summary

The purpose of the NORDIC ICD study is to evaluate whether ICD implantation without intra-operative DF testing is non-inferior to ICD implantation with intra-operative DF testing regarding the efficacy of the first ICD shock for the treatment of true spontaneous ventricular tachyarrhythmias.

Conditions

  • Ventricular Tachyarrhythmia

Interventions

DEVICE

ICD implantation w/o DF test

ICD implantation without Defibrillation Test

DEVICE

ICD implantation with DF test

ICD implantation with DF test according to standardized procedure

Sponsors & Collaborators

  • Biotronik SE & Co. KG

    lead INDUSTRY

Principal Investigators

  • Dietmar Bänsch, Prof. Dr. med. · Rostock University Hospital

  • Johan Brandt, PhD, MD · Skane University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-02-28
Primary Completion
2014-12-31
Completion
2015-05-31

Countries

  • Germany
  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01282918 on ClinicalTrials.gov